These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

4752 related articles for article (PubMed ID: 23850509)

  • 21. Alteration of cardiac glucose metabolism in association to low birth weight: experimental evidence in lambs with left ventricular hypertrophy.
    Wang KC; Lim CH; McMillen IC; Duffield JA; Brooks DA; Morrison JL
    Metabolism; 2013 Nov; 62(11):1662-72. PubMed ID: 23928106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced Activities of Blood Thiamine Diphosphatase and Monophosphatase in Alzheimer's Disease.
    Pan X; Sang S; Fei G; Jin L; Liu H; Wang Z; Wang H; Zhong C
    PLoS One; 2017; 12(1):e0167273. PubMed ID: 28060825
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential levels of apolipoprotein E and butyrylcholinesterase show strong association with pathological signs of Alzheimer's disease in the brain in vivo.
    Darreh-Shori T; Forsberg A; Modiri N; Andreasen N; Blennow K; Kamil C; Ahmed H; Almkvist O; Långström B; Nordberg A
    Neurobiol Aging; 2011 Dec; 32(12):2320.e15-32. PubMed ID: 20538374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hydrogen sulfide slows down progression of experimental Alzheimer's disease by targeting multiple pathophysiological mechanisms.
    Giuliani D; Ottani A; Zaffe D; Galantucci M; Strinati F; Lodi R; Guarini S
    Neurobiol Learn Mem; 2013 Sep; 104():82-91. PubMed ID: 23726868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-chain polyunsaturated fatty acids (LCPUFA) from genesis to senescence: the influence of LCPUFA on neural development, aging, and neurodegeneration.
    Janssen CI; Kiliaan AJ
    Prog Lipid Res; 2014 Jan; 53():1-17. PubMed ID: 24334113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Powerful beneficial effects of benfotiamine on cognitive impairment and beta-amyloid deposition in amyloid precursor protein/presenilin-1 transgenic mice.
    Pan X; Gong N; Zhao J; Yu Z; Gu F; Chen J; Sun X; Zhao L; Yu M; Xu Z; Dong W; Qin Y; Fei G; Zhong C; Xu TL
    Brain; 2010 May; 133(Pt 5):1342-51. PubMed ID: 20385653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oxidative stress and mitochondrial dysfunction-linked neurodegenerative disorders.
    Islam MT
    Neurol Res; 2017 Jan; 39(1):73-82. PubMed ID: 27809706
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum or cerebrospinal fluid levels of glyceraldehyde-derived advanced glycation end products (AGEs) may be a promising biomarker for early detection of Alzheimer's disease.
    Yamagishi S; Nakamura K; Inoue H; Kikuchi S; Takeuchi M
    Med Hypotheses; 2005; 64(6):1205-7. PubMed ID: 15823718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of brain glucose metabolism ameliorating cognitive impairment in APP/PS1 transgenic mice by electroacupuncture.
    Liu W; Zhuo P; Li L; Jin H; Lin B; Zhang Y; Liang S; Wu J; Huang J; Wang Z; Lin R; Chen L; Tao J
    Free Radic Biol Med; 2017 Nov; 112():174-190. PubMed ID: 28756309
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mitochondrial complex I as a therapeutic target for Alzheimer's disease.
    Trushina E; Trushin S; Hasan MF
    Acta Pharm Sin B; 2022 Feb; 12(2):483-495. PubMed ID: 35256930
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regional brain metabolism with cytochrome c oxidase histochemistry in a PS1/A246E mouse model of autosomal dominant Alzheimer's disease: correlations with behavior and oxidative stress.
    Strazielle C; Jazi R; Verdier Y; Qian S; Lalonde R
    Neurochem Int; 2009 Dec; 55(8):806-14. PubMed ID: 19682525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human ApoE Isoforms Differentially Modulate Glucose and Amyloid Metabolic Pathways in Female Brain: Evidence of the Mechanism of Neuroprotection by ApoE2 and Implications for Alzheimer's Disease Prevention and Early Intervention.
    Keeney JT; Ibrahimi S; Zhao L
    J Alzheimers Dis; 2015; 48(2):411-24. PubMed ID: 26402005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting whole body metabolism and mitochondrial bioenergetics in the drug development for Alzheimer's disease.
    Austad SN; Ballinger S; Buford TW; Carter CS; Smith DL; Darley-Usmar V; Zhang J
    Acta Pharm Sin B; 2022 Feb; 12(2):511-531. PubMed ID: 35256932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biomarkers for Early Diagnostic of Mild Cognitive Impairment in Type-2 Diabetes Patients: A Multicentre, Retrospective, Nested Case-Control Study.
    Xu ZP; Yang SL; Zhao S; Zheng CH; Li HH; Zhang Y; Huang RX; Li MZ; Gao Y; Zhang SJ; Zhan PY; Zhang LF; Deng L; Wei S; Liu YC; Ye JW; Ren HJ; Li N; Kong CX; Wang X; Fang L; Zhou QZ; Jiang HW; Li JR; Wang Q; Ke D; Liu GP; Wang JZ
    EBioMedicine; 2016 Mar; 5():105-13. PubMed ID: 27077117
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolism: A Novel Shared Link between Diabetes Mellitus and Alzheimer's Disease.
    Sun Y; Ma C; Sun H; Wang H; Peng W; Zhou Z; Wang H; Pi C; Shi Y; He X
    J Diabetes Res; 2020; 2020():4981814. PubMed ID: 32083135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre-clinical AD, amnestic mild cognitive impairment and late-stage AD.
    Tramutola A; Triplett JC; Di Domenico F; Niedowicz DM; Murphy MP; Coccia R; Perluigi M; Butterfield DA
    J Neurochem; 2015 Jun; 133(5):739-49. PubMed ID: 25645581
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cognitive, behavioral and metabolic effects of oral galactose treatment in the transgenic Tg2576 mice.
    Babic Perhoc A; Osmanovic Barilar J; Knezovic A; Farkas V; Bagaric R; Svarc A; Grünblatt E; Riederer P; Salkovic-Petrisic M
    Neuropharmacology; 2019 Apr; 148():50-67. PubMed ID: 30571958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune system and glucose metabolism interaction in schizophrenia: a chicken-egg dilemma.
    Steiner J; Bernstein HG; Schiltz K; Müller UJ; Westphal S; Drexhage HA; Bogerts B
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():287-94. PubMed ID: 23085507
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alzheimer's disease pathogenesis and therapeutic interventions.
    Parihar MS; Hemnani T
    J Clin Neurosci; 2004 Jun; 11(5):456-67. PubMed ID: 15177383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 238.